LIMN Liminatus Pharma, Inc.

Nasdaq liminatuspharma.com


$ 1.22 $ 0.00 (0 %)    

Tuesday, 21-Oct-2025 11:15:55 EDT
QQQ $ 610.90 $ -0.69 (-0.11 %)
DIA $ 470.40 $ 3.28 (0.7 %)
SPY $ 671.80 $ 0.32 (0.05 %)
TLT $ 92.04 $ 0.05 (0.05 %)
GLD $ 380.26 $ -6.38 (-1.65 %)
$ 1.21
$ 1.21
$ 1.19 x 1
$ 1.22 x 210
$ 1.16 - $ 1.22
$ 1.11 - $ 33.66
228,419
na
28.19M
$ -1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-04-2025 06-30-2025 10-Q
2 05-31-2025 03-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. has entered into a Memorandum of Understanding (MOU) to form a research and development consortium with ...

 us-stocks-likely-to-open-higher-sp-500-sees-average-gain-of-61-in-2nd-half-expert-says

U.S. futures rose on Wednesday after a mixed close on Tuesday. Futures of major benchmark indices were trading slightly higher.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION